Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMayo Clinic
About this trial
To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology
Radiation therapy for curative intent
Disqualifiers
None
Trial population
All patients being treated at Mayo Clinic with photon/ proton therapy.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
analyze acute and late toxicities using CTCAE 4.03
Time frame
Patients will be followed for the duration of their life, an expected average of 20 years2
analyze quality of life using LASA-3 and FACT-E
Time frame
Patients will be followed for the duration of their life, an expected average of 20 yearsSecondary outcomes
1
analyze local control through tumor assessments
Time frame
Patients will be followed for the duration of their life, an expected average of 20 years2
analyze survival by contacting patient and EMR (electronic medical record) review
Time frame
Patients will be followed for the duration of their life, an expected average of 20 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov